COUNTRY of origin labelling
should be voluntary only, the
the Australian Self Medication
Industry (ASMI) advocates in its
submission to the consultation on
the Regulation Impact Statement
(RIS) on the matter.
ASMI regulatory and scientific
affairs director Steve Scarff said
while some sponsors may want
to include a country of origin
statement on labels, this should
not be mandatory “because all
therapeutic goods are already
highly regulated for safety and
quality and all are manufactured
in sites that have been approved
by the Therapeutic Goods
Administration (TGA) - including
overseas sites.”The above article was sent to subscribers in Pharmacy Daily's issue from 02 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Feb 16
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.